| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
* Center for Molecular and Human Genetics, Columbus Children’s Research Institute; and Departments of
Molecular Virology, Immunology, and Medical Genetics and
Pediatrics, Ohio State University, Columbus, OH 43205;
Clinical Division of Nephrology, Innsbruck Medical University, Innsbruck, Austria;
¶ Bruneck Hospital, Bruneck, Italy; and
|| Brixen Hospital, Brixen, Italy
Although a heterozygous deficiency of either complement component C4A or C4B is common, and each has a frequency of 
20% in a Caucasian population, complete deficiencies of both C4A and C4B proteins are extremely rare. In this paper the clinical courses for seven complete C4 deficiency patients are described in detail, and the molecular defects for complete C4 deficiencies are elucidated. Three patients with homozygous HLA A24 Cw7 B38 DR13 had systemic lupus erythematosus, mesangial glomerulonephritis, and severe skin lesions or membranous nephropathy. Immunofixation, genomic restriction fragment length polymorphisms, and pulsed field gel electrophoresis experiments revealed the presence of monomodular RP-C4-CYP21-TNX (RCCX) modules, each containing a solitary, long C4A mutant gene. Sequencing of the mutant C4A genes revealed a 2-bp, GT deletion in exon 13 that leads to protein truncation. The other four patients with homozygous HLA A30 B18 DR7 had SLE, severe kidney disorders including mesangial or membranoproliferative glomerulonephritis, and/or Henoch Schoenlein purpura. Molecular genetic analyses revealed an unusual RCCX structure with two short C4B mutant genes, each followed by an intact gene for steroid 21-hydroxylase. Nine identical, intronic mutations were found in each mutant C4B. In particular, the 8127 g
a mutation present at the donor site of intron 28 may cause an RNA splice defect. Analyses of 12 complete C4 deficiency patients revealed two hot spots of deleterious mutations: one is located at exon 13, the others within a 2.6-kb genomic region spanning exons 20–29. Screening of these mutations may facilitate epidemiologic studies of C4 in infectious, autoimmune, and kidney diseases.
This article has been cited by other articles:
|
|
 |
|
  D.-H. Yang, D.-M. Chang, J.-H. Lai, F.-H. Lin, and C.-H. Chen Usefulness of erythrocyte-bound C4d as a biomarker to predict disease activity in patients with systemic lupus erythematosus Rheumatology, June 24, 2009; (2009) kep161v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Puah, L. Lian, C. Chew, K. Chua, and S. Tan A study of association of the complement C4 mutations with systemic lupus erythematosus in the Malaysian population Lupus, September 1, 2007; 16(9): 750 - 754. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Mehlhop and M. S. Diamond Protective immune responses against West Nile virus are primed by distinct complement activation pathways J. Exp. Med., May 15, 2006; 203(5): 1371 - 1381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S R Block A brief history of twins Lupus, February 1, 2006; 15(2): 61 - 64. [PDF]
|
|
|
|
 |
|
 E. Mehlhop, K. Whitby, T. Oliphant, A. Marri, M. Engle, and M. S. Diamond Complement Activation Is Required for Induction of a Protective Antibody Response against West Nile Virus Infection J. Virol., June 15, 2005; 79(12): 7466 - 7477. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
